Leigh Shaw

Leigh Shaw currently serves as VP of Regulatory Affairs & Quality Assurance at SpliceBio, a leading genetic medicines company focused on innovative gene therapies. Previously, Leigh held senior regulatory roles at Bloomsbury Genetic Therapies, GenSight Biologics, United Neuroscience, and Nightstar Therapeutics, with responsibilities spanning regulatory affairs, quality assurance, and non-clinical safety for various biotech firms specializing in gene therapies for serious diseases. Leigh's career began at Gregory Fryer Associates, where leadership in clinical and regulatory consultancy was established, accompanied by earlier positions in regulatory affairs at Huntingdon Life Sciences and GlaxoSmithKline. Educational credentials include an MBA from The Open University, an MSc in Molecular and Biochemical Parasitology from the University of Salford, and a BSc in Microbiology and Virology from the University of Warwick.